Memorial Şişli Hospital
Memorial Şişli Hospital
Turquia, Istambul
Betul Tavil
29 anos de experiência
acreditações :
Clínica certificada :
O custo da terapia com células-tronco para a doença de Parkinson na Turquia é aproximadamente de $25,000 a $45,000. Este preço inclui o procedimento padrão de terapia com células-tronco. O pacote de tratamento pode abranger vários serviços, como consulta médica, exame, e uma estadia hospitalar de 1 dia com um acompanhante. Além disso, os pacientes recebem uma estadia de 2 dias em hotel após a hospitalização, exame pré-operatório por um especialista em anestesia, taxas de sala de operações, anestesia geral durante a operação e medicamentos usados durante a hospitalização. O pacote também inclui serviços de enfermagem privada, assistência de intérprete durante o processo de tratamento e transferências aeroporto-hotel-hospital/hospital-hotel-aeroporto.
| Turquia | Áustria | Espanha | |
| Terapia com células estaminais para a doença de Parkinson | de $25,000 | de $35,000 | de $30,000 |
O Centro Médico Anadolu — é uma clínica multidisciplinar líder na Turquia. Foi criada e funciona com o apoio da clínica universitária Johns Hopkins (Johns Hopkins Medicine) nos EUA. Graças a isso, o tratamento no Anadolu segue os padrões americanos, utilizando os métodos e tecnologias mais recentes.
Oncologia, onco-hematologia, transplante de medula óssea, neurocirurgia, urologia, check-up, ginecologia e FIV — são áreas especializadas do Anadolu.
A clínica é voltada para pacientes estrangeiros — anualmente, busca atendimento médico aqui de 65 países ao redor do mundo. O Anadolu ocupa o 2º lugar no ranking dos melhores hospitais do mundo para pacientes estrangeiros, segundo a MTQUA.
Pela alta qualidade do atendimento médico e de serviço, a clínica recebeu certificados OECI, ESMO, e o prêmio Planetree.
Dia 1
Dia 2
Dia 3-5
Dia 6
Dia 7-10
Semana 2-4
Semana 5
Semana 6
Por favor, note que o caso de cada paciente é único e o cronograma pode variar com base nas condições individuais e resposta ao tratamento.
O Prof. Baris Topcular, com mais de 20 anos em neurologia, especializa-se em tratamentos avançados, como a terapia com células estaminais para a doença de Parkinson no Hospital Florence Nightingale de Istambul.
O Dr. Asuman Mersin Kokrek tem uma sólida formação em medicina do trabalho e vasta experiência em hospitais de ensino e pesquisa.
O Prof. Karaöz estabeleceu o primeiro centro institucional de pesquisa de células-tronco da Turquia – KÖGEM – e foi pioneiro na produção de células-tronco padrão GMP no Liv Hospital.
O Dr. Anil Gurkan é especialista em terapia com células estaminais para a doença de Parkinson na You Clinic.
O tratamento com células-tronco visa regenerar células cerebrais danificadas para aliviar os sintomas da doença de Parkinson.
Stem cell therapy for Parkinson's in Turkey is an experimental procedure using mesenchymal stem cells to target neurological degeneration. While JCI-accredited clinics like Memorial Şişli Hospital maintain high clinical standards, the treatment remains in clinical trial phases rather than being a standardized, risk-free cure.
Bookimed Expert Insight: Advanced centers like Liv Hospital Ulus integrate GMP-certified laboratories led by specialists like Professor Erdal Karaöz. This infrastructure is critical because the safety of `off-label` stem cell use rests entirely on the clinic’s internal processing standards rather than international pharmacological regulations.
Patient Consensus: Many patients notice a brief `honeymoon` period of improved mobility for 1–3 months, but long-term symptom relief is rarely sustained. Typical feedback highlights that post-injection recovery involves several weeks of managing moderate fatigue and mild site soreness.
Success rates for Parkinson's stem cell therapy remain experimental, with clinical trials showing 86.5% to 100% of participants responding positively to motor symptom reduction. Recent phase 2 data indicates high-dose treatments can improve motor scores by 50% while increasing dopamine activity by 44.7% over 2 years.
Bookimed Expert Insight: Clinical data highlights a major experience gap in regenerative medicine. Professor Erdal Karaöz at Liv Hospital Ulus has published 190 articles and led 400+ stem cell treatments. Choosing a facility with a built-in GMP-certified laboratory, rather than an outpatient clinic, ensures higher cell viability and strictly controlled dosages for neurological protocols.
Patient Consensus: While clinical trials show high response rates, many patients report that initial improvements in tremors or rigidity may only last 2–3 months. It is vital to verify if a clinic uses PET scans to confirm actual dopamine increases rather than relying on subjective physical feelings.
Stem cell therapy cannot cure Parkinson disease as it remains an experimental treatment rather than a proven medical solution. While research into replacing dopamine-producing neurons is promising, current procedures focus on managing motor symptoms like tremors and rigidity rather than stopping the underlying neurodegeneration.
Bookimed Expert Insight: While many Turkish clinics like Liv Hospital Ulus maintain high-tier GMP-compliant laboratories, patients should distinguish between regenerative support and a cure. Leading specialists like Professor Erdal Karaöz emphasize that mesenchymal stem cells are currently used to manage progression, not provide a permanent recovery. Choosing a JCI-accredited facility in Istanbul ensures surgical safety even when the long-term neurological outcome remains clinically unproven.
Patient Consensus: Some travelers report temporary improvements in mood or sleep after treatment. Most find that baseline tremors and rigidity return after several weeks with no lasting changes in disease progression.
Ideal candidates for stem cell treatment include patients with chronic degenerative conditions like Parkinson's, osteoarthritis, or autoimmune diseases who have not responded to conventional therapies. Turkey provides advanced regenerative medicine in JCI-accredited facilities, where specialists use mesenchymal stem cells to reduce pain and improve neurological function.
Bookimed Expert Insight: Clinical data shows a high success rate at centers like Liv Hospital Ulus, which houses Turkey's first GMP-certified stem cell lab. While general stem cell therapy starts at $7,300, specialized Parkinson's protocols range from $25,000 to $45,000. Choosing a university-affiliated clinic like Lokman Hekim often ensures access to the latest allogeneic umbilical cord matrix-derived cell research.
Patient Consensus: Many patients emphasize that having realistic expectations is vital, focusing on gaining extra hours of functional on time daily. They often suggest traveling when symptoms are manageable, as heavy disability can lead to rejection during final clinical evaluations.
Select a Turkish clinic that provides mesenchymal stem cell therapy processed in Current Good Manufacturing Practice (cGMP) certified laboratories. Prioritize facilities with Joint Commission International (JCI) accreditation and neurological oversight by specialists like Professor Erdal Karaoz, who established Turkey's first private GMP stem cell lab.
Bookimed Expert Insight: While many clinics offer stem cell therapy, the infrastructure at Liv Hospital Ulus stands out. Their LivMedCell center was the first private Turkish facility to achieve GMP standards for stem cell production. This technical capacity often correlates with higher patient volumes, as they serve over 330,000 patients annually from 180 countries.
Patient Consensus: Patients emphasize the need for transparency regarding outcomes and warn against clinics making `guaranteed cure` claims. Peer-reviewed trial data and direct coordination with experienced neurologists are considered more reliable than promotional videos.